Analyst Ratings for CME Group Inc. Cl A (CME)Updated: 2017-07-28
CME Group Inc. Cl A (NASDAQ:CME) was awarded an average rating of Overweight from investment analysts following the stock. CME had previously received a consensus rating of Overweight a month ago.
16 analysts issued ratings on the stock, where 9 gave CME a buy rating, 0 issued an overweight rating, 6 gave a hold rating, 1 issued an underweight rating, and 0 issued a sell rating. Today, there are 1 more analysts optimistic about the company future as compared with 90 days ago. Over the same time period, there has been an increase of 0 in the number of analysts with a negative outlook on the stock.
CME was given price targets by several analysts. The maximum price target given was 140, which equates to a potential upside of 15.3 percent. The lowest price target was 106, which equates to a potential downside of -12.7 percent. One must be careful with overanalyzing price targets and ratings due to possible conflicts of interest among the analysts releasing them.
Analysts have revised their earnings estimates downwards for this quarter, by about -1.23 percent on average, compared to last month. The average change in earnings estimates over the last 90 days is -3.23 percent. Over the past 30 days, FY earnings estimates have also changed upwards by 0 percent. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes -0.51 percent.
Another thing investors often look at is the level of agreement among analysts' revisions. Over the past month, 2 analysts increased their quarterly estimates, which can be compared to the 5 analysts that decreased their estimates. During this time, 4 analysts made positive revisions in their estimates for this fiscal year's earnings, while 4 analysts made negative revisions to their fiscal year's estimates.
Analysts estimate earnings of CME to grow at a rate of 4.99 percent. People on Wall Street often look at a company's PEG ratio. A lower PEG ratio is favorable, because that is often interpreted as the company being fairly priced relative to its growth rate. Many investors consider PEG ratios between 0 and 1 as preferrable, even though it may be more relevant to compare the ratio to that of a firm's competitors. CME has a PEG ratio of 5.27.
CME has traded between a high of 127.96 and a low of 98.95 over the past year. Currently the stock is 22.71 percent higher than its low, and below the high by 5.11 percent. CME has a price/earnings ratio of 26.3. Investors typically compare the P/E ratio to a company's peers in the industry. The CME value stock report compares CME to some of its peers using value stock charts. The stock has a market capitalization of $41.24 billion. CME's next earnings release will be on 0000-00-00, which is days away.